Global Leuprolide Acetate Market Insights, Forecast to 2025

Publisher Name :
Date: 20-May-2019
No. of pages: 110
Inquire Before Buying

Leuprolide acetate is a synthetic nonapeptide that is a potent gonadotropin-releasing hormone receptor (GnRHR) agonist used for diverse clinical applications, including the treatment of prostate cancer, endometriosis, uterine fibroids, central precocious puberty and in vitro fertilization techniques. Leuprolide acetate is given by injection into a muscle or under the skin.

Leuprorelin was approved for medical use in the United States in 1985. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. In the United Kingdom a monthly dose costs the NHS about 75.24 pounds. In the United States the equivalent dose has a wholesale cost of 1,011.93 USD.

The global Leuprolide Acetate market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Leuprolide Acetate market based on company, product type, end user and key regions.

This report studies the global market size of Leuprolide Acetate in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Leuprolide Acetate in these regions.

This research report categorizes the global Leuprolide Acetate market by top players/brands, region, type and end user. This report also studies the global Leuprolide Acetate market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- Tolmar Pharmaceuticals

- Varian Pharmed

- Avenit

- Takeda Pharmaceutical

- Sun Pharmaceutical Industries

- Livzon Pharmaceutical

- Beijing Biote Pharmaceutical

- Soho-YImIng

- AbbVie

- Sanofi

- Astellas Pharma

- Abbott

- Merck

- Pfizer

Market size by Product

- Intramuscular

- Subcutaneous

Market size by End User

- Prostate Cancer

- Precocious

- Uterine Fibroid

- Others

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Leuprolide Acetate market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Leuprolide Acetate market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Leuprolide Acetate companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Leuprolide Acetate submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Leuprolide Acetate are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Leuprolide Acetate market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Leuprolide Acetate Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Leuprolide Acetate Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Leuprolide Acetate Market Size Growth Rate by Product
1.4.2 Intramuscular
1.4.3 Subcutaneous
1.5 Market by End User
1.5.1 Global Leuprolide Acetate Market Size Growth Rate by End User
1.5.2 Prostate Cancer
1.5.3 Precocious
1.5.4 Uterine Fibroid
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Leuprolide Acetate Market Size
2.1.1 Global Leuprolide Acetate Revenue 2014-2025
2.1.2 Global Leuprolide Acetate Sales 2014-2025
2.2 Leuprolide Acetate Growth Rate by Regions
2.2.1 Global Leuprolide Acetate Sales by Regions
2.2.2 Global Leuprolide Acetate Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Leuprolide Acetate Sales by Manufacturers
3.1.1 Leuprolide Acetate Sales by Manufacturers
3.1.2 Leuprolide Acetate Sales Market Share by Manufacturers
3.1.3 Global Leuprolide Acetate Market Concentration Ratio (CR5 and HHI)
3.2 Leuprolide Acetate Revenue by Manufacturers
3.2.1 Leuprolide Acetate Revenue by Manufacturers (2014-2019)
3.2.2 Leuprolide Acetate Revenue Share by Manufacturers (2014-2019)
3.3 Leuprolide Acetate Price by Manufacturers
3.4 Leuprolide Acetate Manufacturing Base Distribution, Product Types
3.4.1 Leuprolide Acetate Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Leuprolide Acetate Product Type
3.4.3 Date of International Manufacturers Enter into Leuprolide Acetate Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Leuprolide Acetate Sales by Product
4.2 Global Leuprolide Acetate Revenue by Product
4.3 Leuprolide Acetate Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Leuprolide Acetate Breakdown Data by End User
6 North America
6.1 North America Leuprolide Acetate by Countries
6.1.1 North America Leuprolide Acetate Sales by Countries
6.1.2 North America Leuprolide Acetate Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Leuprolide Acetate by Product
6.3 North America Leuprolide Acetate by End User
7 Europe
7.1 Europe Leuprolide Acetate by Countries
7.1.1 Europe Leuprolide Acetate Sales by Countries
7.1.2 Europe Leuprolide Acetate Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Leuprolide Acetate by Product
7.3 Europe Leuprolide Acetate by End User
8 Asia Pacific
8.1 Asia Pacific Leuprolide Acetate by Countries
8.1.1 Asia Pacific Leuprolide Acetate Sales by Countries
8.1.2 Asia Pacific Leuprolide Acetate Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Leuprolide Acetate by Product
8.3 Asia Pacific Leuprolide Acetate by End User
9 Central & South America
9.1 Central & South America Leuprolide Acetate by Countries
9.1.1 Central & South America Leuprolide Acetate Sales by Countries
9.1.2 Central & South America Leuprolide Acetate Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Leuprolide Acetate by Product
9.3 Central & South America Leuprolide Acetate by End User
10 Middle East and Africa
10.1 Middle East and Africa Leuprolide Acetate by Countries
10.1.1 Middle East and Africa Leuprolide Acetate Sales by Countries
10.1.2 Middle East and Africa Leuprolide Acetate Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Leuprolide Acetate by Product
10.3 Middle East and Africa Leuprolide Acetate by End User
11 Company Profiles
11.1 Tolmar Pharmaceuticals
11.1.1 Tolmar Pharmaceuticals Company Details
11.1.2 Company Business Overview
11.1.3 Tolmar Pharmaceuticals Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Tolmar Pharmaceuticals Leuprolide Acetate Products Offered
11.1.5 Tolmar Pharmaceuticals Recent Development
11.2 Varian Pharmed
11.2.1 Varian Pharmed Company Details
11.2.2 Company Business Overview
11.2.3 Varian Pharmed Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Varian Pharmed Leuprolide Acetate Products Offered
11.2.5 Varian Pharmed Recent Development
11.3 Avenit
11.3.1 Avenit Company Details
11.3.2 Company Business Overview
11.3.3 Avenit Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Avenit Leuprolide Acetate Products Offered
11.3.5 Avenit Recent Development
11.4 Takeda Pharmaceutical
11.4.1 Takeda Pharmaceutical Company Details
11.4.2 Company Business Overview
11.4.3 Takeda Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Takeda Pharmaceutical Leuprolide Acetate Products Offered
11.4.5 Takeda Pharmaceutical Recent Development
11.5 Sun Pharmaceutical Industries
11.5.1 Sun Pharmaceutical Industries Company Details
11.5.2 Company Business Overview
11.5.3 Sun Pharmaceutical Industries Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Sun Pharmaceutical Industries Leuprolide Acetate Products Offered
11.5.5 Sun Pharmaceutical Industries Recent Development
11.6 Livzon Pharmaceutical
11.6.1 Livzon Pharmaceutical Company Details
11.6.2 Company Business Overview
11.6.3 Livzon Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Livzon Pharmaceutical Leuprolide Acetate Products Offered
11.6.5 Livzon Pharmaceutical Recent Development
11.7 Beijing Biote Pharmaceutical
11.7.1 Beijing Biote Pharmaceutical Company Details
11.7.2 Company Business Overview
11.7.3 Beijing Biote Pharmaceutical Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Beijing Biote Pharmaceutical Leuprolide Acetate Products Offered
11.7.5 Beijing Biote Pharmaceutical Recent Development
11.8 Soho-YImIng
11.8.1 Soho-YImIng Company Details
11.8.2 Company Business Overview
11.8.3 Soho-YImIng Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Soho-YImIng Leuprolide Acetate Products Offered
11.8.5 Soho-YImIng Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 Company Business Overview
11.9.3 AbbVie Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.9.4 AbbVie Leuprolide Acetate Products Offered
11.9.5 AbbVie Recent Development
11.10 Sanofi
11.10.1 Sanofi Company Details
11.10.2 Company Business Overview
11.10.3 Sanofi Leuprolide Acetate Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Sanofi Leuprolide Acetate Products Offered
11.10.5 Sanofi Recent Development
11.11 Astellas Pharma
11.12 Abbott
11.13 Merck
11.14 Pfizer
12 Future Forecast
12.1 Leuprolide Acetate Market Forecast by Regions
12.1.1 Global Leuprolide Acetate Sales Forecast by Regions 2019-2025
12.1.2 Global Leuprolide Acetate Revenue Forecast by Regions 2019-2025
12.2 Leuprolide Acetate Market Forecast by Product
12.2.1 Global Leuprolide Acetate Sales Forecast by Product 2019-2025
12.2.2 Global Leuprolide Acetate Revenue Forecast by Product 2019-2025
12.3 Leuprolide Acetate Market Forecast by End User
12.4 North America Leuprolide Acetate Forecast
12.5 Europe Leuprolide Acetate Forecast
12.6 Asia Pacific Leuprolide Acetate Forecast
12.7 Central & South America Leuprolide Acetate Forecast
12.8 Middle East and Africa Leuprolide Acetate Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Leuprolide Acetate Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Leuprolide Acetate Product Picture
Table Leuprolide Acetate Market Segments
Table Key Manufacturers Leuprolide Acetate Covered
Table Global Leuprolide Acetate Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Leuprolide Acetate Sales Market Share by Product 2014-2025
Figure Intramuscular Product Picture
Table Major Manufacturers of Intramuscular
Figure Subcutaneous Product Picture
Table Major Manufacturers of Subcutaneous
Table Global Leuprolide Acetate Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Prostate Cancer
Figure Precocious
Figure Uterine Fibroid
Figure Others
Figure Leuprolide Acetate Report Years Considered
Figure Global Leuprolide Acetate Market Size 2014-2025 (Million US$)
Figure Global Leuprolide Acetate Sales 2014-2025 (K Units)
Table Global Leuprolide Acetate Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Leuprolide Acetate Sales by Regions 2014-2019 (K Units)
Table Global Leuprolide Acetate Sales Market Share by Regions 2014-2019
Figure Global Leuprolide Acetate Sales Market Share by Regions 2014-2019
Figure 2018 Global Leuprolide Acetate Sales Market Share by Regions
Table Global Leuprolide Acetate Revenue by Regions 2014-2019 (Million US$)
Table Global Leuprolide Acetate Revenue Market Share by Regions 2014-2019
Figure Global Leuprolide Acetate Revenue Market Share by Regions 2014-2019
Figure 2018 Global Leuprolide Acetate Revenue Market Share by Regions
Table Global Leuprolide Acetate Sales by Manufacturers (2014-2019) (K Units)
Table Global Leuprolide Acetate Sales Share by Manufacturers (2014-2019)
Figure Global Leuprolide Acetate Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Leuprolide Acetate Revenue by Manufacturers (2014-2019) (Million USD)
Table Leuprolide Acetate Revenue Share by Manufacturers (2014-2019)
Figure Leuprolide Acetate Value Share by Manufacturers in 2018
Table Key Manufacturers Leuprolide Acetate Price (2014-2019) (USD/Unit)
Table Leuprolide Acetate Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Leuprolide Acetate Product Type
Table Date of International Manufacturers Enter into Leuprolide Acetate Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Leuprolide Acetate Sales by Product (2014-2019) (K Units)
Table Global Leuprolide Acetate Sales Share by Product (2014-2019)
Figure Global Leuprolide Acetate Sales Market Share by Product (2014-2019)
Figure Global Leuprolide Acetate Sales Market Share by Product in 2018
Table Global Leuprolide Acetate Revenue by Product (2014-2019) (Million US$)
Table Global Leuprolide Acetate Revenue Share by Product (2014-2019)
Figure Global Leuprolide Acetate Revenue Market Share by Product (2014-2019)
Figure Global Leuprolide Acetate Revenue Market Share by Product in 2018
Table Leuprolide Acetate Price by Product 2014-2019 (USD/Unit)
Table Global Leuprolide Acetate Sales by End User (2014-2019) (K Units)
Table Global Leuprolide Acetate Sales Share by End User (2014-2019)
Figure Global Sales Leuprolide Acetate Market Share by End User (2014-2019)
Figure Global Sales Leuprolide Acetate Market Share by End User in 2018
Figure North America Leuprolide Acetate Sales Growth Rate 2014-2019 (K Units)
Figure North America Leuprolide Acetate Revenue Growth Rate 2014-2019 (Million US$)
Table North America Leuprolide Acetate Sales by Countries (2014-2019) (K Units)
Table North America Leuprolide Acetate Sales Market Share by Countries (2014-2019)
Figure 2018 North America Leuprolide Acetate Sales Market Share by Countries
Table North America Leuprolide Acetate Revenue by Countries (2014-2019) (Million US$)
Table North America Leuprolide Acetate Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Leuprolide Acetate Revenue Market Share by Countries
Figure United States Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure United States Leuprolide Acetate Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Canada Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Table North America Leuprolide Acetate Sales by Product (2014-2019) (K Units)
Table North America Leuprolide Acetate Sales Market Share by Product (2014-2019)
Figure 2018 North America Leuprolide Acetate Market Share by Product
Table North America Leuprolide Acetate Sales by End User (2014-2019) (K Units)
Table North America Leuprolide Acetate Sales Market Share by End User (2014-2019)
Figure 2018 North America Leuprolide Acetate Market Share by End User
Figure Europe Leuprolide Acetate Sales Growth Rate 2014-2019 (K Units)
Figure Europe Leuprolide Acetate Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Leuprolide Acetate Sales by Countries (2014-2019) (K Units)
Table Europe Leuprolide Acetate Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Leuprolide Acetate Sales Market Share by Countries
Table Europe Leuprolide Acetate Revenue by Countries (2014-2019) (Million US$)
Table Europe Leuprolide Acetate Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Leuprolide Acetate Revenue Market Share by Countries
Figure Germany Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Germany Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure France Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure France Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure UK Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Italy Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Russia Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Leuprolide Acetate Sales by Product (2014-2019) (K Units)
Table Europe Leuprolide Acetate Sales Market Share by Product (2014-2019)
Figure 2018 Europe Leuprolide Acetate Market Share by Product
Table Europe Leuprolide Acetate Sales by End User (2014-2019) (K Units)
Table Europe Leuprolide Acetate Sales Market Share by End User (2014-2019)
Figure 2018 Europe Leuprolide Acetate Market Share by End User
Figure Asia Pacific Leuprolide Acetate Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Leuprolide Acetate Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Leuprolide Acetate Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Leuprolide Acetate Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Leuprolide Acetate Sales Market Share by Countries
Table Asia Pacific Leuprolide Acetate Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Leuprolide Acetate Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Leuprolide Acetate Revenue Market Share by Countries
Figure China Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure China Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Japan Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Korea Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure India Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure India Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Australia Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Leuprolide Acetate Sales by Product (2014-2019) (K Units)
Table Asia Pacific Leuprolide Acetate Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Leuprolide Acetate Market Share by Product
Table Asia Pacific Leuprolide Acetate Sales by End User (2014-2019) (K Units)
Table Asia Pacific Leuprolide Acetate Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Leuprolide Acetate Market Share by End User
Figure Central & South America Leuprolide Acetate Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Leuprolide Acetate Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Leuprolide Acetate Sales by Countries (2014-2019) (K Units)
Table Central & South America Leuprolide Acetate Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Leuprolide Acetate Sales Market Share by Countries
Table Central & South America Leuprolide Acetate Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Leuprolide Acetate Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Leuprolide Acetate Revenue Market Share by Countries
Figure Brazil Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Leuprolide Acetate Sales by Product (2014-2019) (K Units)
Table Central & South America Leuprolide Acetate Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Leuprolide Acetate Market Share by Product
Table Central & South America Leuprolide Acetate Sales by End User (2014-2019) (K Units)
Table Central & South America Leuprolide Acetate Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Leuprolide Acetate Market Share by End User
Figure Middle East and Africa Leuprolide Acetate Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Leuprolide Acetate Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Leuprolide Acetate Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Leuprolide Acetate Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Leuprolide Acetate Sales Market Share by Countries
Table Middle East and Africa Leuprolide Acetate Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Leuprolide Acetate Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Leuprolide Acetate Revenue Market Share by Countries
Figure GCC Countries Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Leuprolide Acetate Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Leuprolide Acetate Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Leuprolide Acetate Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Leuprolide Acetate Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Leuprolide Acetate Market Share by Product
Table Middle East and Africa Leuprolide Acetate Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Leuprolide Acetate Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Leuprolide Acetate Market Share by End User
Table Tolmar Pharmaceuticals Company Details
Table Tolmar Pharmaceuticals Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Tolmar Pharmaceuticals Recent Development
Table Varian Pharmed Company Details
Table Varian Pharmed Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Varian Pharmed Recent Development
Table Avenit Company Details
Table Avenit Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Avenit Recent Development
Table Takeda Pharmaceutical Company Details
Table Takeda Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceutical Recent Development
Table Sun Pharmaceutical Industries Company Details
Table Sun Pharmaceutical Industries Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Industries Recent Development
Table Livzon Pharmaceutical Company Details
Table Livzon Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Livzon Pharmaceutical Recent Development
Table Beijing Biote Pharmaceutical Company Details
Table Beijing Biote Pharmaceutical Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Beijing Biote Pharmaceutical Recent Development
Table Soho-YImIng Company Details
Table Soho-YImIng Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Soho-YImIng Recent Development
Table AbbVie Company Details
Table AbbVie Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AbbVie Recent Development
Table Sanofi Company Details
Table Sanofi Leuprolide Acetate Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Astellas Pharma Company Details
Table Abbott Company Details
Table Merck Company Details
Table Pfizer Company Details
Table Global Leuprolide Acetate Sales Forecast by Regions 2019-2025 (K Units)
Table Global Leuprolide Acetate Sales Market Share Forecast by Regions 2019-2025
Table Global Leuprolide Acetate Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Leuprolide Acetate Revenue Market Share Forecast by Regions 2019-2025
Table Global Leuprolide Acetate Sales Forecast by Product 2019-2025 (K Units)
Table Global Leuprolide Acetate Sales Market Share Forecast by Product 2019-2025
Table Global Leuprolide Acetate Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Leuprolide Acetate Revenue Market Share Forecast by Product 2019-2025
Table Global Leuprolide Acetate Sales Forecast by End User 2019-2025 (K Units)
Table Global Leuprolide Acetate Sales Market Share Forecast by End User 2019-2025
Figure North America Leuprolide Acetate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Leuprolide Acetate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Leuprolide Acetate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Leuprolide Acetate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Leuprolide Acetate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Leuprolide Acetate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Leuprolide Acetate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Leuprolide Acetate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Leuprolide Acetate Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Leuprolide Acetate Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Leuprolide Acetate Value Chain
Table Leuprolide Acetate Customers List
Table Leuprolide Acetate Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs